Home
Conditions
Gram-Negative Bacterial Infections

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies

Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Immunology and Safety of Menactra® in Children in Saudi Arabia

NCT00539032

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: AlKhaleej, Al-Qassim Region, Saudi Arabia

AlRabwa, Al-Qassim Region, Saudi Arabia

S. Buraida, Al-Qassim Region, Saudi Arabia

Safra-Al Midhnab, Al-Qassim Region, Saudi Arabia

View Trial Details

Completed

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

NCT00422292

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Tuscaloosa, Alabama, United States

Tucson, Arizona, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 88 locations

View Trial Details

Completed

Immunopathogenesis of Chlamydia

NCT00607659

Conditions: Adnexal Diseases, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

View Trial Details

Completed

Dose Comparison Study of Menactra® in US Children

NCT00700635

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +8 more
Locations: Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

Boca Raton, Florida, United States

Viera, Florida, United States

View all 15 locations

View Trial Details

Completed

Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®

NCT00258895

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Fayetteville, Arkansas, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

Fountain Valley, California, United States

View all 22 locations

View Trial Details

Completed

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

NCT00771849

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: London, United Kingdom

London, United Kingdom

View Trial Details

Completed

Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

NCT00258908

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Taipei, Taiwan

View Trial Details

Completed

Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®

NCT00850603

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations: East Stroudsburg, Pennsylvania, United States

View Trial Details

Completed

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT00384397

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Montgomery, Alabama, United States

Fayetteville, Arkansas, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 39 locations

View Trial Details

Completed

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

NCT00269477

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Atlanta, Georgia, United States

Marietta, Georgia, United States

Woburn, Massachusetts, United States

Akron, Ohio, United States

View Trial Details

Gram-Negative Bacterial Infections

Gram-Negative Bacterial Infections trial results

Related conditions